IRCT201210118698N2已完成未知
Evaluation of N-acetylcystein on biomarkers of platelet activation and coronary reperfusion in patients undergoing percutaneous coronary intervention
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 90 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria:Myocardial infarction patients who were candidate of primary PCI .
排除标准
- •rescue pci;
- •emergency for cardiac bypass ;
- •cardiogenic shock;
- •life expactancy less than 6 months;
- •Age less than 18 years old;
- •Uncontrolled hypertension;
- •Thrombocytopenia;
- •Malformation or aneurysm;
- •sever chronic renal failure;
- •Sever liver failure;
- •treatment with glycoprotein IIb/IIIa inhibitors during PCI ;
- •sensitivity to sulfonamides ;
- •Major surjery;
- •Unsatisfactory to enter to study
研究者
相似试验
Unknown
3 期
Effect of N-acetylcystein in Myocardial InfarctionAcute Myocardial InfarctionNCT01741207Tehran University of Medical Sciences100
已完成
3 期
acetylcysteine administration in treatment of metabolic syndromeMetabolic syndrome.Metabolic syndromeE88.81IRCT20170513033941N72Bagheiat-allah University of Medical Sciences76
招募中
3 期
Evaluation of The Effect of N-acetylcysteine in The Prevention of Vancomycin-Induced Renal Disorder.IRCT20150721023282N6Esfahan University of Medical Sciences60
招募中
2 期
Effect of N-acetylcysteine in the improvement of AphthousRecurrent aphthous stomatitis.Recurrent oral aphthaeIRCT20180728040614N1Sari University of Medical Sciences46
尚未招募
3 期
‘Effectiveness and safety of the use of N-acetylcysteine in patients with kidney failure in leptospirosis’SLCTR/2018/016ational Research Council of Sri Lanka